Among its recommendations, the association said Congress should work to strengthen shortage disclosure requirements for drugmakers, incentivize manufacturers to make contingency plans in case of a shortage and assess drug shortages as a national security threat.
The FDA should work to establish a manufacturing quality rating system, improve its drug shortages list, develop a list of critical drugs and disclose more information on the quality of outsourcing facilities that compound drugs during a shortage, it said.
Read the full news release here.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
